Leverage the Intersection of AI & CDD for Multi-Objective Optimization of Affinity, Thermostability & Immunogenicity to Design Developability-Optimized Biologics with Derisked CMC
AI/ML and computational use cases for biologics design and optimization are at a critical turning point. Latent Labs’ launch to develop biologics using advanced AI models, Eli Lilly’s TuneLab partnering with BigHat Bio and Chai Discovery, and Bayer’s collaboration with Cradle on AI-enabled antibody discovery, emphasize the role of AI as the key accelerant in re-architecting biologics workflows to expedite discovery to lead candidate optimization.
The re-imagined CDD & AI for Biologics Summit returns at this industry-defining moment to deliver key learnings on applied, experimentally validated use cases to support you in catalyzing biologics discovery innovation. Dive into the convergence of computational drug design and AI applications in de novo protein design, property prediction, multi-objective optimization, molecular dynamics mapping and developability assessment for biologics.
Unite with techbio and biotech torchbearers such as Insilico Medicine, insitro, 3T Biosciences, AI Proteins, as well as industry heavyweights of AI adoption, including Eli Lilly, Merck, AstraZeneca, AbbVie and Amgen. This forum is designed to enable you as computational biologists, data scientists, developability specialists, and AI/ML leads to unpack, understand and operationalize the latest AI/ML approaches for biologics design, alongside conventional and innovative computational approaches.
Attend to gather the actionable insights and impactful collaborations required to advance AI-enabled lead biologics through discovery pipelines, with derisked CMC and towards proof of therapeutic value for patients.
The conference has a uniquely intimate and collegial atmosphere where participants are very open and approachable. The discussions will be vibrant, innovative, and genuinely collaborative, making it an inspiring environment to exchange ideas and build meaningful connections
Gabor Oroszlan, Platform Lead, VRG Therapeutics, 2026 Speaker
This is a great opportunity to connect with industry and academic experts on important topics in computational drug discovery for biologics. The focused agenda and smaller setting will allow for more in-depth discussions and a chance to gain valuable insights
Nandhini Rajagopal, Principal Scientist, Computational Biophysics, Genentech, 2026 Speaker
I look forward to gaining exposure to practical strategies for combining high-throughput experimentation with ML, and focusing on real-world implementation, rather than theory alone
Noam Katz, Director, ML & ISR Site Lead, insitro, 2026 Speaker
Having attended before, I'm excited to continue to gain fresh, actionable insights and valuable industry connections that refine our DMTA cycles and improve predictability in candidate selection. It is great to hear real-world case studies and practical validation strategies for AI/ML and de novo approaches that we can apply immediately to our biologics discovery
Lindsay Hammack, Associate Principal Scientist, Merck, 2026 Speaker
Why This Summit is the ‘Best Fit’ For You
Dive into the Brand-New Program to Find:
- 20+ World-Class Computational & AI/ML-Guided Biologics Speakers with Expertise Spanning Discovery, Design & Optimization
- 8+ Hours of Unmatched Networking & Strategic Partnering Opportunities
- 3 Days of Exclusive Content Providing Best-in-Class AI/ML Use Cases & Insights
- 2 Pre-Conference Deep Dive Workshops Offering Perspectives on Data Readiness & Lab Automation for AI-Enabled Biologic Therapeutics Design
- A Focused, Industry-Lead Community of Top Techbio, Pharma & Biotech Organizations
Speaker Faculty
Official Partners
Who You Will Connect With
Discover the 2026 Agenda
Catch the latest industry breakthroughs, emerging trends and exclusive insights by participating in our dynamic roundtables and panel discussions.
Prioritize Partnering With Us
As the field rapidly expands and matures, position yourself alongside leading solution providers to ensure your brand stands out as a premier choice, amid growing competition.
Join Your Community
Immerse yourself in critical conversations with like-minded experts spanning all stages of development, from in silico to de novo biologics design and developability optimization, and build invaluable connections.